Eli Lilly ?Very Much Opposed? to Merger With Another Peer, Says CEO

staying independent in the wake of mega-mergers in the pharmaceutical industry from 2009, that saw Pfizer gobbling up Wyeth , and Merck & Co buying Schering-Plough. A dearth in new drug development had forced all the drugmakers to band together. To...